ShapeTX retweeted
How do you turn AI conversations into real progress? Next week at Benchtalk 2024, Generate’s @tharindi_h, PhD, joins @WillWeiss of @EliLillyandCo and @RonHause from @ShapeTx Inc. to discuss R&D’s toughest challenges. Don’t miss out—details here: benchtalk.benchling.com/bost…
ShapeTX retweeted
Stoked to see @_JosephWatson & @UWproteindesign ace generative diffusion models for protein design! Echoes our RNA design efforts at @ShapeTX. Excited for the therapeutic dev breakthroughs! #generativeAI
nature.com/articles/s41586-0…
ShapeTX retweeted
.@ShapeTx’s Francois Vigneault says the most exciting thing about mRNA is that is could act as a software update for our bodies to cure disease. #AtlanticProgress
ShapeTX retweeted
Please welcome our newest members! GI Cell, @apprentice_io, AffyXell Therapeutics, @bitbio, @ShapeTx, @LyGenesis_Inc, @txrare, Center for Regenerative and Restorative Medicine at @UAZHealth, SCTbio, @Ocugen, and Catenion.
ShapeTX retweeted
"Building a company is hard work. An enduring passion to see one's work to the translational finish line is key.”
Prashant Mali (@prashantgmali) - Associate Professor @UCSanDiego / Serial Entrepreneur
Shoutout: @ShapeTx, @BoundlessBio, among others
ShapeTX retweeted
Top 3 today: #1
As CRISPR horizons cloud, a startup focuses on the next big thing with powerhouse potential — the RNA editing platform
endpts.com/as-crispr-horizon…
ShapeTX retweeted
Replying to @CureDuchenne
@CureDuchenne latest investment is in Shape Therapeutics’s RNA editing platform focused on curing genetic diseases #RNA #DMD #Duchenne cureduchenne.org/press-relea…










